KAYLAN BIFARO: Open Payments
NPI 1629627096 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 13 payments from 6 companies in 2025. Trend: 2023 $600 · 2024 $230 · 2025 $896
Travel & lodging: $661Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $761 |
| Gilead Sciences, Inc. | 3 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| BIOTRONIK NRO, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
Products named: PROCLAIM, ETERNA, Trodelvy, JOURNAVX, RELISTOR, Prospera, Tirosint.
Industry payments across GA — which companies pay providers there.
